RE: BC201 and Fostamatinib22 Aug 2020 01:31
I wrote earlier that the SNG SP was "on its arse" on the Friday before the trial results were released the following Monday.
I accept that when compared to the price it was in January, 37.5p was a huge rise, and that as such, "on its arse" was a poor choice of phrase. However, the point I was making was that the SP was not rising, as the release of the trial results became imminent - something some posters here have suggested , might happen with VAL's SP.
The price of 37.5p, was only fractionally above the SNG's March cash call. - But yet the SP flirted with a level of 70p during April and May, before dwindling to roughly half that level by 17th July.